Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Pol

Showing results (101-110 of 441) with videos related to

Pageof 45
Sort By:
Gastroenterology|October 31, 2002
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition?Christophe Renou, Stanislas Pol, Philippe Halfon, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2021
Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' replyStanislas Pol, Clovis Luzivika Nzinga, Hélène Fontaine, et al.
Journal of Hepatology|January 19, 2011
Viral hepatitis in solid organ transplantation other than liverAnais Vallet-Pichard, Hélène Fontaine, Vincent Mallet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2019
Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?Stanislas Pol, Anaïs Vallet-Pichard, Hélène Fontaine, et al.
Seminars in Nephrology|July 16, 2002
HCV infection and hemodialysisStanislas Pol, Anaïs Vallet-Pichard, Hélène Fontaine, et al.
Medical Microbiology and Immunology|December 17, 2014
Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?Marie-Louise Michel, Maryline Bourgine, Hélène Fontaine, et al.
Journal of Hepatology|May 16, 2021
Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020Vincent Mallet, Nathanael Beeker, Samir Bouam, et al.
Blood|April 11, 2015
Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatmentPhilippe Sultanik, Caroline Klotz, Philippe Brault, et al.
Contributions to Nephrology|February 8, 2012
Hepatitis C: epidemiology, diagnosis, natural history and therapyStanislas Pol, Anaïs Vallet-Pichard, Marion Corouge, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 9, 2009
Why actively promote vaccination in patients with cirrhosis?Pierre Loulergue, Stanislas Pol, Vincent Mallet, et al.
Pageof 45

Showing results (101-110 of 441) with videos related to

Sort By:
Pageof 45
Gastroenterology|October 31, 2002
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition?Christophe Renou, Stanislas Pol, Philippe Halfon, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2021
Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' replyStanislas Pol, Clovis Luzivika Nzinga, Hélène Fontaine, et al.
Journal of Hepatology|January 19, 2011
Viral hepatitis in solid organ transplantation other than liverAnais Vallet-Pichard, Hélène Fontaine, Vincent Mallet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 23, 2019
Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?Stanislas Pol, Anaïs Vallet-Pichard, Hélène Fontaine, et al.
Seminars in Nephrology|July 16, 2002
HCV infection and hemodialysisStanislas Pol, Anaïs Vallet-Pichard, Hélène Fontaine, et al.
Medical Microbiology and Immunology|December 17, 2014
Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?Marie-Louise Michel, Maryline Bourgine, Hélène Fontaine, et al.
Journal of Hepatology|May 16, 2021
Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020Vincent Mallet, Nathanael Beeker, Samir Bouam, et al.
Blood|April 11, 2015
Regression of an HCV-associated disseminated marginal zone lymphoma under IFN-free antiviral treatmentPhilippe Sultanik, Caroline Klotz, Philippe Brault, et al.
Contributions to Nephrology|February 8, 2012
Hepatitis C: epidemiology, diagnosis, natural history and therapyStanislas Pol, Anaïs Vallet-Pichard, Marion Corouge, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 9, 2009
Why actively promote vaccination in patients with cirrhosis?Pierre Loulergue, Stanislas Pol, Vincent Mallet, et al.
Pageof 45